Questions over dabigatran education for GPs

MARKETING dabigatran to general practitioners could lead to the drug being prescribed for patients in whom it has not been proven to be safe or effective, according to an editorial in the Internal Medicine Journal.

Please Login to Access Medical Observer

If you have an account select Login. If you are new to Medical Observer select Join.

Login Join

Author:

Lynnette Hoffman

Lynnette Hoffman is an award-winning science and medical journalist and heatlh copywriter.